Next Article in Journal
Two New Pentacyclic Triterpene Saponins from the Leaves of Akebia trifoliata
Next Article in Special Issue
Prenylated Chalcone 2 Acts as an Antimitotic Agent and Enhances the Chemosensitivity of Tumor Cells to Paclitaxel
Previous Article in Journal
Synthesis, Characterization, and Retinol Stabilization of Fatty Amide-β-cyclodextrin Conjugates
Previous Article in Special Issue
Marine Natural Products as Models to Circumvent Multidrug Resistance
Open AccessReview

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau SAR 999078, China
*
Author to whom correspondence should be addressed.
Academic Editor: Helena Vasconcelos
Molecules 2016, 21(7), 965; https://doi.org/10.3390/molecules21070965
Received: 10 June 2016 / Revised: 16 July 2016 / Accepted: 19 July 2016 / Published: 22 July 2016
(This article belongs to the Special Issue New Approaches to Counteract Drug Resistance in Cancer)
Epithelial–mesenchymal transition (EMT) is known to play an important role in cancer progression, metastasis and drug resistance. Although there are controversies surrounding the causal relationship between EMT and cancer metastasis, the role of EMT in cancer drug resistance has been increasingly recognized. Numerous EMT-related signaling pathways are involved in drug resistance in cancer cells. Cells undergoing EMT show a feature similar to cancer stem cells (CSCs), such as an increase in drug efflux pumps and anti-apoptotic effects. Therefore, targeting EMT has been considered a novel opportunity to overcome cancer drug resistance. This review describes the mechanism by which EMT contributes to drug resistance in cancer cells and summarizes new advances in research in EMT-associated drug resistance. View Full-Text
Keywords: epithelial–mesenchymal transition; drug resistance; chemotherapy; cancer stem cells epithelial–mesenchymal transition; drug resistance; chemotherapy; cancer stem cells
Show Figures

Graphical abstract

MDPI and ACS Style

Du, B.; Shim, J.S. Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules 2016, 21, 965. https://doi.org/10.3390/molecules21070965

AMA Style

Du B, Shim JS. Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules. 2016; 21(7):965. https://doi.org/10.3390/molecules21070965

Chicago/Turabian Style

Du, Bowen; Shim, Joong S. 2016. "Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer" Molecules 21, no. 7: 965. https://doi.org/10.3390/molecules21070965

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop